Dr. John Cush RheumNow
5 years 7 months ago
Survery of 438 RHEUMS on #AS & SpA - half use mod NY & ASAS criteria. 3/4 say Inflammatory Back Pain is axSpA specific, ~1/2 say uveitis/dactylitis are “very specific; less so heel enthesitis, peripheral arthritis. SI MRI was mor common w/ younger Rheums https://t.co/xfjvK5TO0t
Dr. John Cush RheumNow
5 years 7 months ago
Medscape has published the 2021 Rheumatologist Lifestyle, Happiness & Burnout Report.
Happy went down during COVID 79% to 49%
32% burnt out; 11% depressed
51% have workplace issues
Half take 3-4 wks vacation
https://t.co/g8UAHtiLIB
Dr. John Cush RheumNow
5 years 7 months ago
Single center study of 43 pregnant SLE pts (57 pregnancies) - 96.5% intended to breast feed & 72% did (same as gen population). But SLE women had more early discontinuations @ 3 mos (assoc w/ smoking, BMI, joint Dz) HCQ assoc w/ longer breastfeeding https://t.co/VVVTVUeOT5
Katz, Arant and Loeser have published a comprehensive open-read overview of osteoarthritis (OA) of the hip and knee in JAMA; underscoring the impact, advances, disappointments and guidelines put forth.
Dr. John Cush RheumNow
5 years 7 months ago
Population based study of smoking cessation & risk of TKR in knee OA. TKR higher in recent quitters (26.7/1000PY vs 17.4/1000PY in smokers). adjusted HR=1.30 (95%CI:1.05-1.59). TKR risk was higher among quitters with weight gain (HR=1.42) https://t.co/6onQWQeFcI
Dr. John Cush RheumNow
5 years 7 months ago
CTD associated pulmonary HTN has improved sincd 2010. Metanalysis of 11 RCTs (4,329 pts) & 19 registries (9,739 pts); 5 RCTs find PAH Rx assoc w/ 36% lower mortality/morbidity. Registry data shows better PAH survival since 2010 (73% vs 65% @3yrs) https://t.co/0BkO70AQfi
Dr. John Cush RheumNow
5 years 7 months ago
Analysis of incident #RA in UK Clinical Practice registry shows recent prednisone >=7.5mg/d is assoc w/ hypertension in RA. In 17760 RA pts, 42% were Rx steroids; recent GC yielded a 17% increase in HTN (HR 1.17); only >7.5mg/D implicated https://t.co/qUKs2oZZUV https://t.co/pWmD4nKs6U
Arthritis & Rheumatology has published the results of a subanalysis from tocilizumab (TCZ) clinical trials showing that Il-6 inhibition was associated with preservation of lung function patients with early systemic sclerosis (SSc).
Dr. John Cush RheumNow
5 years 7 months ago
QD Clinic - When to do Genetic Testing in Febrile Patients
Indications for Genetic testing for autoinflammatory disorders
https://t.co/1vnR1JQAxZ https://t.co/x2wyLHhjgN
Dr. John Cush RheumNow
5 years 7 months ago
QD Clinic - Hemoptysis and SLE
Key Features of Alveolar Hemorrhage in lupus
https://t.co/qNZYDYmn70 https://t.co/sitc7Tlf5V
Dr. John Cush RheumNow
5 years 7 months ago
RheumNow Podcast is now up! Systemic Sclerosis Pearls
Dr. Jack Cush reviews nearly a dozen news and journal reports from the past 2 weeks on https://t.co/fxtCOkxTER,
https://t.co/nKRmKWR0Bd https://t.co/ESdycxLoCz
Dr. John Cush RheumNow
5 years 7 months ago
High Risk Cancer Profiling with Inflammatory Myositis
A recent metanalysis of studies suggest you may be able to use certain clinical factors to stratify cancer risk in patients with idiopathic inflammatory myopathies (IIMs).
https://t.co/TjmdGtdDQG https://t.co/tlfVU031fY
Dr. John Cush RheumNow
5 years 7 months ago
QD Clinics - Traveling to Medical Meetings during COVID
Is it Safe to Travel?
https://t.co/flELrZbjnw https://t.co/ixebtW71fx
Dr. John Cush RheumNow
5 years 7 months ago
Avacopan - Is it Really a Win for ANCA-Associated Vasculitis?
The NEJM has reported the results of a study showing that avacopan, a C5a receptor inhibitor, is as effective as steroids at treating patients with ANCA-AAV.
https://t.co/vWmhEhX8Z3 https://t.co/omXpouPKoJ
